Moreover, AZGP1 has been identified as a prognostic marker for prostate cancer [7], breast cancer [8], [9], and gastric cancer [10], and it acts as a novel tumor suppressor in pancreatic cancer [11]. This evidence concerns the gene AZGP1 and familial pancreatic carcinoma.